Abstract
Craniopharyngiomas are rare intracranial tumors of epithelial origin. They are characterized by infiltrating adjacent structures such as the hypothalamus, pituitary gland and optic chiasm. There are two histological lineages, adamantinomatous and the papillary type, which is found almost exclusively in the adult population. Despite its nonspecific manifestations, the diagnostic suspicion is based on clinical findings and imaging techniques. However, the definitive diagnosis is made through histopathological studies. Craniopharyngioma is considered the most frequent sellar neoplasm in the pediatric population and can negatively impact their growth and development. Although it has an excellent survival, it generates high morbidity in patients, both before and after their treatment. For this reason, the most recent advances in the treatment of craniopharyngioma have focused on minimizing adverse effects and secondary morbidities.
This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. The authors keep the copyright and publication rights in the journal the right of the first publication and this possibility to edit, reproduce, distribute, expose and publicly communicate on the magazine's website. Likewise, it assumes the commitment on any litigation or claim related to the rights of intellectual property, exonerating of responsibility to the Science and Health Magazine of the UCIMED. In addition, you can see how they are published in this journal (eg, Include in an institutional repository or publish it in a book) as long as they clearly indicate the work published for the first time in the magazine Science and Health of the UCIMED.